Davide Bonazzi
Illustrator
From this contributor
Company on brink takes psilocybin to trial for fragile X syndrome
The phase 2A trial has its detractors despite positive animal results and is being sponsored by a company that is struggling financially.
Company on brink takes psilocybin to trial for fragile X syndrome
Explore more from The Transmitter
Dutch primate center awaits October animal research debate
Science is forging ahead at the Biomedical Primate Research Centre in the Netherlands, following a reversal of last year’s mandate to phase out primate studies. But researchers aren’t sure how long the reprieve will last.
Dutch primate center awaits October animal research debate
Science is forging ahead at the Biomedical Primate Research Centre in the Netherlands, following a reversal of last year’s mandate to phase out primate studies. But researchers aren’t sure how long the reprieve will last.
When we sleep, our brain is filled with spontaneous neural activity. What is it doing?
Daniel Levenstein explains how internally generated brain activity during sleep shapes our cognition, and why NeuroAI is such a powerful approach to understanding the brain.
When we sleep, our brain is filled with spontaneous neural activity. What is it doing?
Daniel Levenstein explains how internally generated brain activity during sleep shapes our cognition, and why NeuroAI is such a powerful approach to understanding the brain.
Unconfounding genetic and environmental factors, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 31 August.
Unconfounding genetic and environmental factors, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 31 August.